This American Depositary Receipt (ADR) represent shares in Lonza, a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. Its offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications.